{"name":"American Research Corporation","slug":"american-research-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"paritaprevir/ritonavir/ombitasvir + dasabuvir +/- ribavirin","genericName":"paritaprevir/ritonavir/ombitasvir + dasabuvir +/- ribavirin","slug":"paritaprevir-ritonavir-ombitasvir-dasabuvir-ribavirin","indication":"Chronic hepatitis C virus (HCV) infection, genotypes 1a and 1b, with or without cirrhosis","status":"marketed"}]}],"pipeline":[{"name":"paritaprevir/ritonavir/ombitasvir + dasabuvir +/- ribavirin","genericName":"paritaprevir/ritonavir/ombitasvir + dasabuvir +/- ribavirin","slug":"paritaprevir-ritonavir-ombitasvir-dasabuvir-ribavirin","phase":"marketed","mechanism":"This combination inhibits hepatitis C virus (HCV) replication by blocking multiple viral enzymes essential for viral protein processing and RNA synthesis.","indications":["Chronic hepatitis C virus (HCV) infection, genotypes 1a and 1b, with or without cirrhosis","HCV genotype 1 infection in treatment-naïve and treatment-experienced patients"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuAJBVV95cUxNR3BRZHRLNjVoaDlxQnA1R0dGcXdsdDMzRXlOYS0zV0Z6MWlILTVqNjFuLWt4aXlaZTNySEZwM2FTM3VJeHFWYy1UWkJia29GS1pFcDRKTEwtam50QnpicEJLUTBNTktMUjlGOGNBREt6S19rOHVBdnBGd3gycFZlNWxtVHF3dG1tcC1HQk10QzZWNC1xVG14WjlCR3FxYUVPamVRX2YwbEFib1YzRWhYZTA1VHEwbEU2MjZ6NU42OU5DUUp2VkhRTW0tSXNtQS1kSnV6M0lncXB0QTF1bE1UdjZqRk5ncmhmd0Ezc1o1VmV5SF9ld2FSc0dPX1c4YUMtNEhzUUdVMjF6M3dMdFQtYll6T2JEODVuRTVRNnFIQXE5T3c2Y1J4TGd4eFg4dHRlYXdQX1Fxc1k?oc=5","date":"2026-03-24","type":"pipeline","source":"GlobeNewswire","summary":"Zealand Pharma Establishes U.S. Research Hub in Cambridge, - GlobeNewswire","headline":"Zealand Pharma Establishes U.S. Research Hub in Cambridge,","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQQzVpTjY1ZU1fandlWnZjTXQ4aFJFQkcxOEswNDBTNFEwVGtaNXMwTC1RUFRsWTRvS19aYnF2ZlZaVXZrclZOTlVIdTVBNDlPZVdsQ0RrMThuV0NHcFI3OVdKcm4xZ3lMS1VPam5rckRldm1wVmRGRVc5NHdzRUg4czAya281cnVSV1J4NVZTOXQ4RFNWdldnQWtjd0R3WU5UcHVKRDFCN3ZxUGc?oc=5","date":"2026-02-19","type":"pipeline","source":"Statista","summary":"U.S. pharmaceutical R&D expenditure 2024 - Statista","headline":"U.S. pharmaceutical R&D expenditure 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPZlFCRE0tR09IcFR6RXFhYmRTeTcyRTVrT3ByNHUzRXN4VFFBZExzMGtmNkNwa09NX0VFd3EzaUhSVmZpSTJkRFlqOFBuYVNpWHNBLWE3WjlkMjM2bWVhYS1zYTllbnRHb1JKV0l5ZlQzTEFaSmUzYW5pS2NiRkowZVZLU183Z0dsM2psTjZhVG5UNDdBTzM4?oc=5","date":"2026-02-14","type":"pipeline","source":"The Motley Fool","summary":"Best Pharmaceutical Stocks for 2026 and How to Invest in Them - The Motley Fool","headline":"Best Pharmaceutical Stocks for 2026 and How to Invest in Them","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxOV0hnUENDN1dnVWNRTlFreTh0X1A3Sm9kVzlkNndjWkRfUGl3aVNjOVdidE5mZThMcVZ4aEotMDh3Sm1kckQ4TGxMTEFGRkRjWmpqSXlqaXZlR2ppWlhob3RyYUVEemF4V3JEUm9WdUNGcGVOd2JjazdZWUp0b3hrLVBBdG1YMUpWZWdtek5QRHEwQjRLMFZ0eHpqeFRJVEN4emlFQUZmSk9OSlNGWDg1V3lUaGZmZlJvWU5GQTl0VmwtOFpJMXlyYURDVkg3ME43WTN3dA?oc=5","date":"2026-01-08","type":"pipeline","source":"Contract Pharma","summary":"AstraZeneca Taps Rick Suarez as US President & Head of the US Biopharmaceuticals Business Unit - Contract Pharma","headline":"AstraZeneca Taps Rick Suarez as US President & Head of the US Biopharmaceuticals Business Unit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxOLU1qMkloenpyVHBQTDBzb1lNdk1VYVVLWFFPS0Z0RXFMWjlRT3E4bDM0X2lEdTNmOEZBRXdBU0s1bV9obWNsVUZMcC1kWWlKUV9NTlp6YWFsYjR6SW5FVEdqdmhqcVhMUHBtMnFtZEs0YVdrenRwY1pqVUVXLXBSeDM2S0FfY3hMREtCeTYwZ3BDTU9CMVBxendlNDVhNDZoUXVSUVZwelpFdFgtUWw3Y3k3YUYwTUVBMGhaUzFVWHJNWnMySFRVQTBncThMbFJWRjFnM0NCQkg0d0xqc0VMbWQ3Y2RpdHEtR3JXZV9KMGNGb1dtblE?oc=5","date":"2026-01-02","type":"pipeline","source":"PR Newswire","summary":"Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering - PR Newswire","headline":"Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-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?oc=5","date":"2025-12-03","type":"earnings","source":"simplywall.st","summary":"Sun Pharma Advanced Research Company Limited (NSE:SPARC) surges 21%; private companies who own 46% shares profited along with insiders - simplywall.st","headline":"Sun Pharma Advanced Research Company Limited (NSE:SPARC) surges 21%; private companies who own 46% shares profited along","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxOVnU2UmYwZjZOSGQ0VGdrcEdfbVhhQ09Ga2JKZVFXVVBZTHhZeUdOSF9naXROc280UndrcmIxQjhPV1RHcFl1Wjd3ekFwUFNpVFB5WFdfQVh5SnQyUXFRUGpfZU9Pd2Z5NmlVV0VWUi1GNVk1dGE1YVgtOGFITVlPZGcwbGZndW1fb01ZREJoRW5kY0xHTEZSSTNKZlNpSnkxNHJ5WkpGeV9PQXlXSG1iX3FfaFZkWElPV0pqZWRFV2hsd0NFR2FYczgydm1wdGhCMlItY0N2VzUzYTFSZ2NsS2tuMDg3Tmc?oc=5","date":"2025-09-17","type":"pipeline","source":"Reuters","summary":"GSK commits $30 billion to US research and development, factory expansion, as Trump visits UK - Reuters","headline":"GSK commits $30 billion to US research and development, factory expansion, as Trump visits UK","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTFBmaVEtNU1Jc0U0aWtYVFRhTFY1d1lUa2ZWa3RKbG1mSXB0TGozMmF6WUFEUzVQQm9xWjdCOG13WFlHTUFWSk5DVXdKSjk3Z3BHQzlvUjFFTWxRdw?oc=5","date":"2025-09-17","type":"pipeline","source":"bbc.com","summary":"GSK pledges $30bn US investment as UK's pharma woes deepen - bbc.com","headline":"GSK pledges $30bn US investment as UK's pharma woes deepen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNTkRyUm83WWRaeEpLR0pPSWk2NEdjb2RhaktLQ2xfemVLZWYwZ3NRZVlKcllzbHg3enZWelpaYlZZTS1iYUdaSml4NWt4aUwwZzZZX1VkcnB1MTQ1ckIzc0IwUE1fMy16a0FBYlhQWVpjNVY2anVFZXN5T0RTQ0NTMHNTV3EzWXhJc3FSbldOdE9vanFveWFBT1J4eGo1dVBqUWEta2hR?oc=5","date":"2025-08-20","type":"pipeline","source":"Cybernews","summary":"Ransomware attack hits Inotiv, big pharma research firm fined millions for animal cruelty - Cybernews","headline":"Ransomware attack hits Inotiv, big pharma research firm fined millions for animal cruelty","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPdndkelh1ZDEwcjF6MXNkRFBCSUdpWFM3ckJzQmMtRkNYalRmc0d0Uzl2bFNWQ0NnVGtIYUtWMzRuX3AzOG5QRUxDazZSLVJLZlZHUEFqWmxhMkRmMUdMM3BaWXdzS0ZiclA1M2dfa2VzdU10X0Nfb1cyakp2TEtucV9zc1g3eGQxOHVaMGFpQlFrbFZHQnFlRTZPaTNtbWtSb3Fsdk9KNnFQSzlCRUJjaklrTUxfanRWb3lKdjZNS1c?oc=5","date":"2025-06-17","type":"pipeline","source":"Reuters","summary":"China pharma projects disrupted by Sino-US tensions - Reuters","headline":"China pharma projects disrupted by Sino-US tensions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9mcjRFZm56aFFEX2xrRlYza0ZmNDg1eVVXZXB3OEhhbVh1enREeUFzMVRXZVVPRkFKcFkwZ2dsYWx4amtOc0xoZWNZNmE3ZjgzWDJuNGdHSFZ3Rk5hamVkRnpCQlZla2F5aGh0NzRRZmlSZjBEbEp1Qw?oc=5","date":"2025-05-09","type":"pipeline","source":"otsuka.co.jp","summary":"Pharmavite Established a New Facility in Ohio, US, Dedicated to The Manufacturing of Gummy SupplementsFacilitating the Research and Development of Gummy Products｜May 9, 2025｜News Releases | Otsuka Pha","headline":"Pharmavite Established a New Facility in Ohio, US, Dedicated to The Manufacturing of Gummy SupplementsFacilitating the R","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNYlFTODBJODhmV0Z4RHNOMnhzZzJ0UW5iNlgyaXFVVTdBWldZZXp4VEpJLWJaUVVzODVQODhVXzlITDZ4Mks3YnJkQmFWVlRvWFNBRDJTcDJiVE9XYkxvaDN4c2g0eFJ2a2RqXzJxQWNXWGNyeFM1clNFaGJDM3JGQ3RoUkozZ3dXaXhkNnBfUXVJdw?oc=5","date":"2025-03-14","type":"pipeline","source":"Council on Foreign Relations","summary":"American Pharmaceutical Companies Still Aren’t Paying Tax in the U.S. - Council on Foreign Relations","headline":"American Pharmaceutical Companies Still Aren’t Paying Tax in the U.S.","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}